A novel biguanide derivative, IM176, induces prostate cancer cell death by modulating the AMPK-mTOR and androgen receptor signaling pathways

BACKGROUND: Metformin and phenformin, biguanide derivatives that are widely used to treat type 2 diabetes mellitus, have recently been shown to exert potential anticancer effects in prostate cancer. This study compared the antiprostate cancer effects of the novel biguanide derivative IM176 with thos...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yunlim, Yoo, Sangjun, Lim, Bumjin, Hong, Jun Hyuk, Kwak, Cheol, You, Dalsan, Hwang, Jung Jin, Kim, Choung-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318334/
https://www.ncbi.nlm.nih.gov/pubmed/37409095
http://dx.doi.org/10.1016/j.prnil.2022.11.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318334/
https://www.ncbi.nlm.nih.gov/pubmed/37409095
http://dx.doi.org/10.1016/j.prnil.2022.11.003

Ejemplares similares